Hamilton Lane Incorporated (HLNE)
NASDAQ: HLNE · Real-Time Price · USD
182.82
+0.21 (0.12%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Company Description

Hamilton Lane Incorporated is a private equity and venture capital firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies.

The firm manages alternative investment strategies like direct credit, direct, fund of fund, evergreen and real assets.

For primary and secondary fund of fund investments, the firm focuses to invest in private equity, buyout, special situations, credit, growth equity, middle market, mature, turnarounds, mezzanine and venture capital funds.

It prefers to invest in energy, industrials, commercial services, internet software & services, consumer discretionary, health care, real estate, information technology, tech-enabled businesses, financials, utilities, and consumer services.

The firm prefers to invest in Africa/Middle East, Asia/Pacific, Europe, Latin America and Caribbean, United States of America, California and surrounding states, Australia, Japan, United Kingdom, and Canada.

The firm prefers to invest between $1 million and $100 million in companies with small- to mid-sized enterprise values.

It prefers to take majority stake. Hamilton Lane Incorporated was founded in 1991 and is based in Conshohocken, Pennsylvania with additional offices across Europe, North America, Asia Pacific and the Middle East.

Hamilton Lane Incorporated
Hamilton Lane logo
Country United States
Founded 1991
IPO Date Mar 1, 2017
Industry Asset Management
Sector Financials
Employees 700
CEO Erik R. Hirsch

Contact Details

Address:
110 Washington Street, Suite 1300
Philadelphia, Pennsylvania 19428
United States
Phone 610 934 2222
Website hamiltonlane.com

Stock Details

Ticker Symbol HLNE
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001433642
CUSIP Number 407497106
ISIN Number US4074971064
Employer ID 26-2482738
SIC Code 6282

Key Executives

Name Position
Dr. Juan M. Delgado-Moreira C.F.A., Ph.D. Co-Chief Executive Officer and Member of the Board
Erik R. Hirsch Co-Chief Executive Officer and Member of the Board
Mario Lucio Giannini J.D. Executive Co-Chairman
Andrea F. Kramer Chief Operating Officer and Chief Risk Officer
Jeffrey B. Armbrister Chief Financial Officer and Treasurer
Drew T. Carl CPA MD and Chief Accounting Officer
Lydia A. Gavalis General Counsel and Secretary
Hartley Raymond Rogers Executive Co-Chairman
Andrew Schardt Vice Chairman, Head of Investment Strategy and Co-Head of Direct Equity
Thomas J. Kerr Co-Head of Investments and Head of Secondary Investments

Latest SEC Filings

Date Type Title
Oct 11, 2024 8-K Current Report
Oct 7, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Sep 18, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Sep 5, 2024 S-8 Securities to be offered to employees in employee benefit plans
Sep 5, 2024 8-K Current Report
Aug 6, 2024 10-Q Quarterly Report
Aug 6, 2024 8-K Current Report
Jul 25, 2024 ARS Filing
Jul 25, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Jul 25, 2024 DEF 14A Other definitive proxy statements